Zejula (niraparib)

pCPA File Number: 21484

Negotiation Status:

Concluded with an LOI

Indication(s):

Ovarian Cancer: Maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CADTH Project Number:

PC0224

pCPA Engagement Letter Issued:

2021-06-01

Negotiation Process Concluded:

2021-08-11